Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane Metered Dose Inhaler

- Asthma | Chronic Obstructive Pulmonary Disease (COPD) | Emphysema | Chronic Bronchitis
- Completed

Study Title: A Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI)

Teva Identifier: ABM-AS-307

ClinicalTrials.gov Identifier: NCT01302587

Study Status: Completed

Trial Condition(s): Asthma | Chronic Obstructive Pulmonary Disease (COPD) | Emphysema | Chronic Bronchitis

Interventions: Drug: Albuterol

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child, Adult, Older Adult

Age Range: 4 Years and older

Trial Duration: 03/01/2011 - 06/01/2011

Study Type

Observational